Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Inventory (2016 - 2025)

China Pharma Holdings filings provide 16 years of Change in Inventory readings, the most recent being -$210551.0 for Q4 2025.

  • On a quarterly basis, Change in Inventory rose 58.8% to -$210551.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$589761.0, a 63.3% increase, with the full-year FY2025 number at -$589761.0, up 63.3% from a year prior.
  • Change in Inventory hit -$210551.0 in Q4 2025 for China Pharma Holdings, down from -$57779.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $552686.0 in Q1 2023 to a low of -$679042.0 in Q2 2021.
  • Median Change in Inventory over the past 5 years was -$210972.0 (2021), compared with a mean of -$194030.0.
  • Biggest five-year swings in Change in Inventory: crashed 6335.2% in 2021 and later surged 311.81% in 2022.
  • China Pharma Holdings' Change in Inventory stood at -$255815.0 in 2021, then rose by 24.59% to -$192902.0 in 2022, then crashed by 34.09% to -$258659.0 in 2023, then crashed by 97.56% to -$510996.0 in 2024, then skyrocketed by 58.8% to -$210551.0 in 2025.
  • The last three reported values for Change in Inventory were -$210551.0 (Q4 2025), -$57779.0 (Q3 2025), and -$164804.0 (Q2 2025) per Business Quant data.